Effect of Nitric Oxide on Naphthoquinone Toxicity in Endothelial Cells: Role of Bioenergetic Dysfunction and Poly(ADP-ribose) Polymerase Activation

被引:23
作者
Broniowska, Katarzyna A. [1 ]
Diers, Anne R. [1 ]
Corbett, John A. [2 ]
Hogg, Neil [1 ]
机构
[1] Med Coll Wisconsin, Dept Biophys, Redox Biol Program, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
OXIDATIVE STRESS; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; CELLULAR BIOENERGETICS; SUPEROXIDE GENERATION; NITROSATIVE STRESS; INDUCED APOPTOSIS; S-NITROSOTHIOLS; CYTO-TOXICITY; REDOX STATUS;
D O I
10.1021/bi400342t
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When produced at physiological levels, reactive oxygen species (ROS) can act as signaling molecules to regulate normal vascular function. Produced under pathological conditions, ROS can contribute to the oxidative damage of cellular components (e.g., DNA and proteins) and trigger cell death. Moreover, the reaction of superoxide with nitric oxide (NO) produces the strong oxidant peroxynitrite and decreases NO bioavailability, both of which may contribute to activation of cell death pathways. The effects of ROS generated from the 1,4-naphthoquinones alone and in combination with NO on the activation status of poly(ADP-ribose) polymerase (PARP) and cell viability were examined. Treatment with redox cycling quinones activates PARP, and this stimulatory effect is attenuated in the presence of NO. Mitochondria play a central role in cell death signaling pathways and are a target of oxidants. We show that simultaneous exposure of endothelial cells to NO and ROS results in mitochondrial dysfunction, ATP and NAD(+) depletion, and cell death. Alone, NO and ROS have only minor effects on cellular bioenergetics. Further, PARP inhibition does not attenuate reduced cell viability or mitochondrial dysfunction. These results show that concomitant exposure to NO and ROS impairs energy metabolism and triggers PARP-independent cell death. While superoxide-mediated PARP activation is attenuated in the presence of NO, PARP inhibition does not modify the loss of mitochondrial function or adenine and pyridine nucleotide pools and subsequent bioenergetic dysfunction. These findings suggest that the mechanisms by which ROS and NO induce endothelial cell death are closely linked to the maintenance of mitochondrial function and not overactivation of PARP.
引用
收藏
页码:4364 / 4372
页数:9
相关论文
共 50 条
  • [41] Genetic inactivation of poly (ADP-ribose) polymerase and endothelial nitric oxide synthase prevents energy failure and oxidative damage in the mouse brain during septic shock
    Czapski, GA
    Cakala, M
    Strosznajder, JB
    POLISH JOURNAL OF PHARMACOLOGY, 2003, 55 (05): : 821 - 867
  • [42] Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
    Faraoni, Isabella
    Consalvo, Maria Irno
    Aloisio, Francesca
    Fabiani, Emiliano
    Giansanti, Manuela
    Di Cristino, Francesca
    Falconi, Giulia
    Tentori, Lucio
    Di Veroli, Ambra
    Curzi, Paola
    Maurillo, Luca
    Niscola, Pasquale
    Lo-Coco, Francesco
    Graziani, Grazia
    Voso, Maria Teresa
    CANCERS, 2019, 11 (09)
  • [43] The pathogenesis of diabetic complications:: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity
    Kiss, L
    Szabó, C
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2005, 100 : 29 - 37
  • [44] Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions
    Ul Islam, Badar
    Habib, Safia
    Ali, Syed Amaan
    Moinuddin
    Ali, Asif
    CARDIOVASCULAR TOXICOLOGY, 2017, 17 (04) : 373 - 383
  • [45] Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways
    Mabley, JG
    Pacher, P
    Bai, P
    Wallace, R
    Goonesekera, S
    Virag, L
    Southan, GJ
    Szabó, C
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 548 (1-2) : 107 - 116
  • [46] Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension
    Shafiq, Mohammad
    Lone, Zahid Rasool
    Abdulkareem, Adam Olaitan
    Kaur, Gurpreet
    Navya, Sai
    Singh, Himalaya
    Jagavelu, Kumaravelu
    Hanif, Kashif
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [47] Poly-ADP-ribosylation in health and diseasePathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation
    K. Erdélyi
    E. Bakondi
    P. Gergely
    C. Szabó
    L. Virág
    Cellular and Molecular Life Sciences CMLS, 2005, 62 : 751 - 759
  • [48] Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?
    Gutierrez-Quintana, Rodrigo
    Walker, David J.
    Williams, Kaye J.
    Forster, Duncan M.
    Chalmers, Anthony J.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [49] DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics
    Rabenau, Karen
    Hofstatter, Erin
    CLINICAL THERAPEUTICS, 2016, 38 (07) : 1577 - 1588
  • [50] The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review
    Patel, Mausam
    Nowsheen, Somaira
    Maraboyina, Sanjay
    Xia, Fen
    CELL AND BIOSCIENCE, 2020, 10 (01)